These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34804933)
1. Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities. Aanei CM; Veyrat-Masson R; Selicean C; Marian M; Rigollet L; Trifa AP; Tomuleasa C; Serban A; Cherry M; Flandrin-Gresta P; Tardy ET; Guyotat D; Campos Catafal L Front Oncol; 2021; 11():746951. PubMed ID: 34804933 [TBL] [Abstract][Full Text] [Related]
2. Advanced Flow Cytometry Analysis Algorithms for Optimizing the Detection of "Different From Normal" Immunophenotypes in Acute Myeloid Blasts. Aanei CM; Veyrat-Masson R; Rigollet L; Stagnara J; Tavernier Tardy E; Daguenet E; Guyotat D; Campos Catafal L Front Cell Dev Biol; 2021; 9():735518. PubMed ID: 34650981 [TBL] [Abstract][Full Text] [Related]
3. The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalities. Jakovic L; Bogdanovic A; Djordjevic V; Dencic-Fekete M; Kraguljac-Kurtovic N; Knezevic V; Tosic N; Pavlovic S; Terzic T Leuk Res; 2018 Dec; 75():23-28. PubMed ID: 30445236 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365 [TBL] [Abstract][Full Text] [Related]
5. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894 [TBL] [Abstract][Full Text] [Related]
6. The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1. Shang L; Chen X; Liu Y; Cai X; Shi Y; Shi L; Li Y; Song Z; Zheng B; Sun W; Ru K; Mi Y; Wang J; Wang H Int J Lab Hematol; 2019 Feb; 41(1):23-31. PubMed ID: 30264491 [TBL] [Abstract][Full Text] [Related]
8. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Zelezníková T; Babusíková O Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719 [TBL] [Abstract][Full Text] [Related]
9. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias. Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670 [TBL] [Abstract][Full Text] [Related]
11. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833 [TBL] [Abstract][Full Text] [Related]
12. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML. Das N; Gupta R; Gupta SK; Bakhshi S; Malhotra A; Rai S; Singh S; Prajapati VK; Sahoo RK; Gogia A; Sharma A; Kumar L Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e673-e684. PubMed ID: 32561191 [TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. Kang LC; Dunphy CH Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553 [TBL] [Abstract][Full Text] [Related]
14. Secondary chromosomal abnormalities in acute leukemias. Johansson B; Mertens F; Mitelman F Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775 [TBL] [Abstract][Full Text] [Related]
16. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Arber DA; Carter NH; Ikle D; Slovak ML Hum Pathol; 2003 May; 34(5):479-83. PubMed ID: 12792922 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometry in the diagnosis of acute leukemia. Weir EG; Borowitz MJ Semin Hematol; 2001 Apr; 38(2):124-38. PubMed ID: 11309694 [TBL] [Abstract][Full Text] [Related]
18. Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going. Dix C; Lo TH; Clark G; Abadir E J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32503122 [TBL] [Abstract][Full Text] [Related]